IBM's Technical Bounce: A Short Squeeze, Not a Turnaround
Published on 07/25/2026 at 17:42 | Redaktion boerse-global.de
A 3.74 percent gain on any given Friday might normally signal renewed buying interest. For IBM, it signals something far less encouraging: the reflexive snap-back of a stock that had simply fallen too far, too fast.
The blue-chip technology giant closed the week at €188.38, a modest recovery from the 52-week low of €175.14 it touched just two days earlier. But that low itself was the product of a catastrophic single-day collapse on July 14, when IBM suffered the worst trading session in its 114-year history, plunging 25 percent after releasing preliminary second-quarter results that badly missed expectations.
The July Shock That Changed the Narrative
The scale of the miss explains the severity of the sell-off. Adjusted earnings per share came in at $2.93, falling short of the $2.97 to $3.01 range analysts had been forecasting. Revenue of $17.16 billion also disappointed against projections of roughly $17.58 billion, delivering a meager 1 percent year-over-year growth rate.
The culprit was unmistakable: the mainframe business. IBM's z-System sales cratered 42 percent in the quarter, dragging the entire infrastructure segment down 7 percent to $3.84 billion. Chief Executive Arvind Krishna attributed the weakness to customers pulling forward hardware purchases ahead of anticipated price increases — a demand-pull effect that has now created a painful vacuum. The company slashed its 2026 growth forecast from above 5 percent to a range of 4 to 5 percent.
Should investors sell immediately? Or is it worth buying IBM?
Chief Financial Officer James Kavanaugh pushed back against the notion that clients are abandoning the mainframe platform, insisting the company expects "significant strength" in the program during the second half of the year. The software segment, IBM's largest and most profitable division, did grow 5 percent to $7.76 billion. But the damage to market confidence was done.
Anatomy of a Technical Recovery
Friday's gain looks less like conviction buying and more like short-covering after an extended rout. The relative strength index (RSI-14) sits at 35.5, a level that historically has preceded technical stabilization. The stock's 30-day annualized volatility has spiked to roughly 85 percent, meaning violent counter-moves are the norm rather than the exception.
Yet the technical picture remains unmistakably bearish. IBM trades well below both its 50-day moving average of €228.64 and its 200-day moving average of €233.84 — a classic downtrend configuration. The stock now sits 35.7 percent below its 52-week high of €292.85 and has lost 27.52 percent since the start of the year.
The analyst community has responded with unusual divergence. While Argus slashed its price target, other firms maintained their ratings — a split that reflects genuine uncertainty about near-term execution. The average analyst target stands at €231.11, implying roughly 22.7 percent upside from current levels. But IBM has looked "cheap" multiple times during this sell-off without forming a sustainable floor.
Dividends as an Anchor
Despite the turbulence, one pillar of the investment case remains intact. IBM confirmed its regular quarterly dividend of $1.69 per share, extending a payout streak that has run uninterrupted since 1916. The commitment signals that management views the current cash-flow generation as sufficient to maintain shareholder returns even through a cyclical downturn in hardware sales.
IBM at a turning point? This analysis reveals what investors need to know now.
Krishna continues to frame the AI transformation as the long-term catalyst, pointing to the company's positioning across software, infrastructure and consulting. The quantum computing ambitions and the much-discussed AI order book remain part of the narrative, though neither is generating meaningful near-term cash flow.
What Comes Next
The question for investors is whether the lowered growth forecast represents a floor or the beginning of a longer adjustment period. If the mainframe cycle normalizes after the pulled-forward demand works its way through, the second half of the year could bring a recovery in infrastructure revenue. If the weakness proves structural — if customers are genuinely shifting budgets away from legacy systems toward newer architectures — the pain could persist.
For now, the Friday bounce looks like an overdue relief rally in an oversold stock, not evidence that the fundamental questions from the July shock have been answered. With the stock nearly 20 percent below both key moving averages and volatility remaining elevated, IBM remains a name for patient, valuation-conscious investors — not for those betting on a confirmed trend change.
Ad
IBM Stock: New Analysis - 25 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
